Ramosetron
Ramosetron is a pharmaceutical drug with 33 clinical trials. Currently 1 active trials ongoing. Historical success rate of 95.0%.
Success Metrics
Based on 19 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
3
Mid Stage
14
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
95.0%
19 of 20 finished
5.0%
1 ended early
1
trials recruiting
33
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Special Drug Use Surveillance of Irribow in Female Patients
The Safety and Efficacy of 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Fecal Incontinence
5-HT3 Receptor Antagonist (Ramosetron) vs Loperamide for the Treatment of Low Anterior Resection Syndrome(RALARS)
Ramosetron OD Tablet and Postdischarge Nausea and Vomiting
Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg Position
Clinical Trials (33)
Special Drug Use Surveillance of Irribow in Female Patients
The Safety and Efficacy of 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Fecal Incontinence
5-HT3 Receptor Antagonist (Ramosetron) vs Loperamide for the Treatment of Low Anterior Resection Syndrome(RALARS)
Ramosetron OD Tablet and Postdischarge Nausea and Vomiting
Effect of Ramosetron on Heart Rate-corrected QT Interval During Robot-assisted Laparoscopic Prostatectomy With Steep Trendelenburg Position
Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis
Therapeutic Efficacy of Ramosetron for Treatment of Established PONV After Laparoscopic Surgery
Effect of Ramosetron on Post-discharge Nausea and Vomiting
Ramosetron Pre-treatment for PONV and QT Prolongation
Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 Polymorphism
Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus Aprepitant
A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and Nausea
Effect of Ramosetron on Bowel Motility After Gynecological Surgery
Clinical Trial Assessing 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Anterior Resection Syndrome
Effect of Ramosetron in Prevention of Intrathecal Morphine Induced Nausea and Vomiting
Efficacy Study of Antiemetics to Reduce Postoperative Nausea and Vomiting
Anti Emetic Efficacy of Combination of Ramosetron and Premixture of Naloxone With Patient-controlled Analgesia
The Effects of Gabapentin and Ramosetron on Postoperative Nausea and Vomiting in Laparoscopic Gynecological Surgery
The Efficacy and Safety of Ramosetron in Patients Undergoing Off Pump Coronary Artery Bypass Surgery
Analgesia Effects of Nalbuphine vs Sulfentanil
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 33